SECFilings.com helps investors track public company disclosures with smart tools and real-time alerts. Trusted by thousands of investors daily.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Form 8-K - Current report - Item 2.02 Item 9.01
Form 8-K - Current report - Item 8.01 Item 9.01
Form 8-K - Current report - Item 8.01 Item 9.01
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Form 8-K - Current report - Item 5.02 Item 7.01 Item 9.01
Form 8-K - Current report - Item 8.01
Form 8-K - Current report - Item 2.02 Item 9.01
Form 8-K - Current report - Item 2.06
Form 8-K - Current report - Item 2.02 Item 9.01
Form 8-K - Current report - Item 5.02
Form S-8 - Securities to be offered to employees in employee benefit plans
Form S-8 - Securities to be offered to employees in employee benefit plans
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 8-K - Current report - Item 2.02 Item 9.01
Form 8-K - Current report - Item 2.02 Item 9.01
Form 8-K - Current report - Item 5.03 Item 9.01
Form S-8 - Securities to be offered to employees in employee benefit plans
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 8-K - Current report - Item 2.02 Item 9.01
Form 8-K - Current report - Item 2.02 Item 9.01
Form 11-K - Annual report of employee stock purchase, savings and similar plans
Form 8-K/A - Current report: [Amend] - Item 5.02 Item 5.07
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 8-K - Current report - Item 2.02 Item 9.01
Form 8-K - Current report - Item 2.02 Item 9.01
Form 8-K - Current report - Item 8.01 Item 9.01
Form S-8 - Securities to be offered to employees in employee benefit plans
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Form 8-K - Current report - Item 5.02 Item 7.01 Item 9.01
Form 8-K - Current report - Item 7.01 Item 9.01
Form 8-K - Current report - Item 2.02 Item 9.01
Form 8-K - Current report - Item 2.02 Item 9.01
Form 8-K - Current report - Item 7.01 Item 9.01
Form 8-K - Current report - Item 7.01 Item 9.01
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 8-K - Current report - Item 2.02 Item 9.01
Form 8-K - Current report - Item 5.02
Form 8-K - Current report - Item 2.02 Item 9.01
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 8-K - Current report - Item 2.02 Item 9.01
Form 8-K - Current report - Item 2.02 Item 9.01
Form 8-K - Current report - Item 5.02
Form 11-K - Annual report of employee stock purchase, savings and similar plans
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Form 8-K - Current report - Item 5.07
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 8-K - Current report - Item 2.02 Item 9.01
Form 8-K - Current report - Item 2.02 Item 9.01
Form 8-K - Current report - Item 1.01 Item 2.03 Item 9.01
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]